{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:47:33Z","timestamp":1793411253881,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-024-01943-w","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T03:43:20Z","timestamp":1733370200000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["The CCL5\/CCR5\/SHP2 axis sustains Stat1 phosphorylation and activates NF-\u03baB signaling promoting M1 macrophage polarization and exacerbating chronic prostatic inflammation"],"prefix":"10.1186","volume":"22","author":[{"given":"Chen","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Pirozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,5]]},"reference":[{"issue":"2","key":"1943_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41391-023-00645-7","volume":"27","author":"T Cai","year":"2023","unstructured":"Cai T, Alidjanov J, Palagin I, Medina-Polo J, Nickel JC, Wagenlehner FME. Chronic prostatitis\/chronic pelvic pain syndrome (CP\/CPPS): look to the future. Prostate Cancer Prostatic Dis. 2023;27(2):239\u201341.","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"1943_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.eururo.2015.08.061","volume":"69","author":"G Magistro","year":"2016","unstructured":"Magistro G, Wagenlehner FM, Grabe M, Weidner W, Stief CG, Nickel JC. Contemporary management of chronic prostatitis\/chronic pelvic pain syndrome. Eur Urol. 2016;69:286\u201397.","journal-title":"Eur Urol"},{"key":"1943_CR3","doi-asserted-by":"publisher","first-page":"14099","DOI":"10.1111\/jcmm.16021","volume":"24","author":"M Zhang","year":"2020","unstructured":"Zhang M, Liu Y, Chen J, Chen L, Meng J, Yang C, Yin S, Zhang X, Zhang L, Hao Z, et al. Single-cell multi-omics analysis presents the landscape of peripheral blood T-cell subsets in human chronic prostatitis\/chronic pelvic pain syndrome. J Cell Mol Med. 2020;24:14099\u2013109.","journal-title":"J Cell Mol Med"},{"key":"1943_CR4","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3389\/fimmu.2017.00898","volume":"8","author":"ML Breser","year":"2017","unstructured":"Breser ML, Salazar FC, Rivero VE, Motrich RD. Immunological mechanisms underlying chronic pelvic pain and prostate inflammation in chronic pelvic pain syndrome. Front Immunol. 2017;8:898.","journal-title":"Front Immunol"},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41467-022-29719-1","volume":"13","author":"RE Vickman","year":"2022","unstructured":"Vickman RE, Aaron-Brooks L, Zhang R, Lanman NA, Lapin B, Gil V, Greenberg M, Sasaki T, Cresswell GM, Broman MM, et al. TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease. Nat Commun. 2022;13:2133.","journal-title":"Nat Commun"},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nri702","volume":"2","author":"JJ O'Shea","year":"2002","unstructured":"O\u2019Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol. 2002;2:37\u201345.","journal-title":"Nat Rev Immunol"},{"key":"1943_CR7","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/andr.13571","volume":"12","author":"SY Yue","year":"2024","unstructured":"Yue SY, Niu D, Ma WM, Guan Y, Liu QS, Wang XB, Xiao YZ, Meng J, Ding K, Zhang L, et al. The CXCL10\/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K\/AKT pathway. Andrology. 2024;12:1408\u201318.","journal-title":"Andrology"},{"key":"1943_CR8","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.2147\/JIR.S352336","volume":"15","author":"M Zhang","year":"2022","unstructured":"Zhang M, Liu Y, Chen J, Chen L, Zhang L, Chen X, Hao Z, Liang C. Targeting CXCL12\/CXCR4 signaling with AMD3100 might selectively suppress CXCR4+ T-cell chemotaxis leading to the alleviation of chronic prostatitis. J Inflamm Res. 2022;15:2551\u201366.","journal-title":"J Inflamm Res"},{"key":"1943_CR9","doi-asserted-by":"publisher","first-page":"R580","DOI":"10.1152\/ajpregu.00240.2012","volume":"303","author":"ML Quick","year":"2012","unstructured":"Quick ML, Mukherjee S, Rudick CN, Done JD, Schaeffer AJ, Thumbikat P. CCL2 and CCL3 are essential mediators of pelvic pain in experimental autoimmune prostatitis. Am J Physiol Regul Integr Comp Physiol. 2012;303:R580\u2013589.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"12","key":"1943_CR10","doi-asserted-by":"publisher","first-page":"e13438","DOI":"10.1111\/ijcp.13438","volume":"73","author":"J Meng","year":"2019","unstructured":"Meng J, Liu Y, Guan SY, Ma H, Zhang X, Fan S, Hu H, Zhang M, Liang C. Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients. Int J Clin Pract. 2019;73(12):e13438.","journal-title":"Int J Clin Pract."},{"key":"1943_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/S0022-5347(05)67497-6","volume":"164","author":"RB Nadler","year":"2000","unstructured":"Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, Yarnold PR, Schaeffer AJ. IL-1beta and TNF-alpha in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol. 2000;164:214\u20138.","journal-title":"J Urol"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41423-019-0279-0","volume":"17","author":"M Li","year":"2020","unstructured":"Li M, Sun X, Zhao J, Xia L, Li J, Xu M, Wang B, Guo H, Yu C, Gao Y, et al. CCL5 deficiency promotes liver repair by improving inflammation resolution and liver regeneration through M2 macrophage polarization. Cell Mol Immunol. 2020;17:753\u201364.","journal-title":"Cell Mol Immunol"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s10753-012-9547-1","volume":"36","author":"G Li","year":"2013","unstructured":"Li G, Zhu G, Gao Y, Xiao W, Xu H, Liu S, Tu G, Peng H, Zheng C, Liang S, Li G. Neferine inhibits the upregulation of CCL5 and CCR5 in vascular endothelial cells during chronic high glucose treatment. Inflammation. 2013;36:300\u20138.","journal-title":"Inflammation"},{"key":"1943_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12967-023-04044-3","volume":"21","author":"J Lin","year":"2023","unstructured":"Lin J, Xu Y, Guo P, Chen YJ, Zhou J, Xia M, Tan B, Liu X, Feng H, Chen Y. CCL5\/CCR5-mediated peripheral inflammation exacerbates blood-brain barrier disruption after intracerebral hemorrhage in mice. J Transl Med. 2023;21:196.","journal-title":"J Transl Med"},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.106.685230","volume":"115","author":"CM Matter","year":"2007","unstructured":"Matter CM, Handschin C. RANTES (regulated on activation, normal T cell expressed and secreted), inflammation, obesity, and the metabolic syndrome. Circulation. 2007;115:946\u20138.","journal-title":"Circulation"},{"key":"1943_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jaci.2023.02.028","volume":"152","author":"M Gauthier","year":"2023","unstructured":"Gauthier M, Kale SL, Oriss TB, Gorry M, Ramonell RP, Dalton K, Ray P, Fahy JV, Seibold MA, Castro M, et al. CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma. J Allergy Clin Immunol. 2023;152:94\u2013106.e112.","journal-title":"J Allergy Clin Immunol"},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"29406","DOI":"10.1074\/jbc.M112.348946","volume":"287","author":"O Chan","year":"2012","unstructured":"Chan O, Burke JD, Gao DF, Fish EN. The chemokine CCL5 regulates glucose uptake and AMP kinase signaling in activated T cells to facilitate chemotaxis. J Biol Chem. 2012;287:29406\u201316.","journal-title":"J Biol Chem"},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/hep.32458","volume":"76","author":"M Huang","year":"2022","unstructured":"Huang M, Jiao J, Cai H, Zhang Y, Xia Y, Lin J, Shang Z, Qian Y, Wang F, Wu H, et al. C-C motif chemokine ligand 5 confines liver regeneration by down-regulating reparative macrophage-derived hepatocyte growth factor in a forkhead box O 3a-dependent manner. Hepatology. 2022;76:1706\u201322.","journal-title":"Hepatology"},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2019.10.029","volume":"179","author":"S Jiao","year":"2019","unstructured":"Jiao S, Subudhi SK, Aparicio A, Ge Z, Guan B, Miura Y, Sharma P. Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy. Cell. 2019;179:1177\u20131190.e1113.","journal-title":"Cell"},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/pros.24395","volume":"82","author":"X Hua","year":"2022","unstructured":"Hua X, Zhang J, Ge S, Liu H, Du H, Niu Q, Chen X, Yang C, Zhang L, Liang C. CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation. Prostate. 2022;82:1223\u201336.","journal-title":"Prostate"},{"key":"1943_CR21","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/bju.15117","volume":"126","author":"RD Motrich","year":"2020","unstructured":"Motrich RD, Breser ML, Molina RI, Tissera A, Olmedo JJ, Rivero VE. Patients with chronic prostatitis\/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self-reactive immune responses specific to prostate and seminal antigens and diminished semen quality. BJU Int. 2020;126:379\u201387.","journal-title":"BJU Int"},{"key":"1943_CR22","doi-asserted-by":"publisher","first-page":"915218","DOI":"10.3389\/fimmu.2022.915218","volume":"13","author":"HX Du","year":"2022","unstructured":"Du HX, Yue SY, Niu D, Liu C, Zhang LG, Chen J, Chen Y, Guan Y, Hua XL, Li C, et al. Gut Microflora Modulates Th17\/Treg Cell Differentiation in Experimental Autoimmune Prostatitis via the Short-Chain Fatty Acid Propionate. Front Immunol. 2022;13:915218.","journal-title":"Front Immunol"},{"issue":"10","key":"1943_CR23","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/jnci\/djae120","volume":"116","author":"S Liu","year":"2024","unstructured":"Liu S, Rivero SL, Zhang B, Shen K, Li Z, Niu T, Rowan BG, Jazwinski SM, Abdel Mageed AB, Steele C, et al. Batf-Dependent Th17 cells act through IL23R pathway to promote prostate adenocarcinoma initiation and progression. J Natl Cancer Inst. 2024;116(10):1598\u2013611.","journal-title":"J Natl Cancer Inst."},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/j.pain.0000000000000405","volume":"157","author":"RD Motrich","year":"2016","unstructured":"Motrich RD, Breser ML, S\u00e1nchez LR, Godoy GJ, Prinz I, Rivero VE. IL-17 is not essential for inflammation and chronic pelvic pain development in an experimental model of chronic prostatitis\/chronic pelvic pain syndrome. Pain. 2016;157:585\u201397.","journal-title":"Pain"},{"key":"1943_CR25","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1158\/2326-6066.CIR-13-0073","volume":"1","author":"Y Yin","year":"2013","unstructured":"Yin Y, Huang X, Lynn KD, Thorpe PE. Phosphatidylserine-targeting antibody induces M1 macrophage polarization and promotes myeloid-derived suppressor cell differentiation. Cancer Immunol Res. 2013;1:256\u201368.","journal-title":"Cancer Immunol Res"},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12964-024-01828-y","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang C, Feng R, Meng T, Peng W, Song J, Ma W, Xu W, Chen X, Chen J, Liang C. CXCR4 regulates macrophage M1 polarization by altering glycolysis to promote prostate fibrosis. Cell Commun Signal. 2024;22:456.","journal-title":"Cell Commun Signal"},{"key":"1943_CR27","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1056\/NEJMoa0803152","volume":"359","author":"RM Gulick","year":"2008","unstructured":"Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, et al. Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med. 2008;359:1429\u201341.","journal-title":"N Engl J Med"},{"key":"1943_CR28","doi-asserted-by":"crossref","unstructured":"Hunt PW, Shulman NS, Hayes TL, Dahl V, Somsouk M, Funderburg NT, McLaughlin B, Landay AL, Adeyemi O, Gilman LE, et al: The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood. 2013;121:4635\u20134646.","DOI":"10.1182\/blood-2012-06-436345"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.1241475","volume":"341","author":"Q Tan","year":"2013","unstructured":"Tan Q, Zhu Y, Li J, Chen Z, Han GW, Kufareva I, Li T, Ma L, Fenalti G, Li J, et al. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex. Science. 2013;341:1387\u201390.","journal-title":"Science"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"953403","DOI":"10.3389\/fimmu.2022.953403","volume":"13","author":"J Meng","year":"2022","unstructured":"Meng J, Jin C, Li J, Zhang S, Zhang M, Hao Z, Chen X, Song Z, Zhang L, Liang C. Metabolomics analysis reveals the differential metabolites and establishes the therapeutic effect prediction nomogram among CP\/CPPS patients who respond or do not respond to LiST. Front Immunol. 2022;13:953403.","journal-title":"Front Immunol."},{"key":"1943_CR31","doi-asserted-by":"publisher","first-page":"835.e831","DOI":"10.1016\/j.ajog.2021.12.021","volume":"226","author":"H Jiang","year":"2022","unstructured":"Jiang H, Shi H, Chen L, Yang J, Yuan P, Wang W, Pang Y, Wei Y, Zhao Y. Is there a relationship between plasma, cytokine concentrations, and the subsequent risk of postpartum hemorrhage? Am J Obstet Gynecol. 2022;226:835.e831\u2013835.e817.","journal-title":"Am J Obstet Gynecol"},{"key":"1943_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4049\/jimmunol.177.2.957","volume":"177","author":"RD Motrich","year":"2006","unstructured":"Motrich RD, Maccioni M, Ponce AA, Gatti GA, Oberti JP, Rivero VE. Pathogenic consequences in semen quality of an autoimmune response against the prostate gland: from animal models to human disease. J Immunol. 2006;177:957\u201367.","journal-title":"J Immunol"},{"key":"1943_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1463-1326.2011.01402.x","volume":"13","author":"A Kumar","year":"2011","unstructured":"Kumar A, Negi G, Sharma SS. JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes Obes Metab. 2011;13:750\u20138.","journal-title":"Diabetes Obes Metab"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1038\/s41467-022-34871-9","volume":"13","author":"N Li","year":"2022","unstructured":"Li N, Liu Q, Han Y, Pei S, Cheng B, Xu J, Miao X, Pan Q, Wang H, Guo J, et al. ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression. Nat Commun. 2022;13:7281.","journal-title":"Nat Commun"},{"key":"1943_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.febslet.2004.06.056","volume":"571","author":"HM Shin","year":"2004","unstructured":"Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park HJ, Hong JT, Min KR, Kim Y. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett. 2004;571:50\u20134.","journal-title":"FEBS Lett"},{"key":"1943_CR36","doi-asserted-by":"publisher","first-page":"R1268","DOI":"10.1152\/ajpregu.00836.2007","volume":"294","author":"CN Rudick","year":"2008","unstructured":"Rudick CN, Schaeffer AJ, Thumbikat P. Experimental autoimmune prostatitis induces chronic pelvic pain. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1268\u20131275.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1943_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/pros.23252","volume":"77","author":"ML Breser","year":"2017","unstructured":"Breser ML, Motrich RD, Sanchez LR, Rivero VE. Chronic Pelvic Pain Development and Prostate Inflammation in Strains of Mice With Different Susceptibility to Experimental Autoimmune Prostatitis. Prostate. 2017;77:94\u2013104.","journal-title":"Prostate"},{"key":"1943_CR38","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/pros.24205","volume":"81","author":"J Chen","year":"2021","unstructured":"Chen J, Meng J, Jin C, Mo F, Ding Y, Gao X, Zhang L, Zhang M, Liang C. 4-Methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy for chronic prostatitis. Prostate. 2021;81:1078\u201390.","journal-title":"Prostate"},{"issue":"6","key":"1943_CR39","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/andr.13571","volume":"12","author":"SY Yue","year":"2023","unstructured":"Yue SY, Niu D, Ma WM, Guan Y, Liu QS, Wang XB, Xiao YZ, Meng J, Ding K, Zhang L, et al. The CXCL10\/CXCR3 axis regulates Th1 cell differentiation and migration in experimental autoimmune prostatitis through the PI3K\/AKT pathway. Andrology. 2023;12(6):1408\u201318.","journal-title":"Andrology"},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12:357\u201360.","journal-title":"Nat Methods"},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"e1009730","DOI":"10.1371\/journal.pcbi.1009730","volume":"18","author":"A Shumate","year":"2022","unstructured":"Shumate A, Wong B, Pertea G, Pertea M. Improved transcriptome assembly using a hybrid of long and short reads with StringTie. PLoS Comput Biol. 2022;18:e1009730.","journal-title":"PLoS Comput Biol."},{"key":"1943_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015;33:290\u20135.","journal-title":"Nat Biotechnol"},{"key":"1943_CR43","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.","journal-title":"Nucleic Acids Res"},{"key":"1943_CR44","doi-asserted-by":"crossref","unstructured":"Wickham H: ggplot2: Elegant Graphics for Data Analysis. 2016.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"1943_CR45","unstructured":"pheatmap: Pretty Heatmaps https:\/\/github.com\/raivokolde\/pheatmap"},{"key":"1943_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"1943_CR47","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/7445","volume":"5","author":"DA Frank","year":"1999","unstructured":"Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med. 1999;5:444\u20137.","journal-title":"Nat Med"},{"key":"1943_CR48","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/sj.leu.2402895","volume":"17","author":"L Sanhes","year":"2003","unstructured":"Sanhes L, Tang R, Delmer A, DeCaprio JA, Ajchenbaum-Cymbalista F. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases. Leukemia. 2003;17:1104\u201311.","journal-title":"Leukemia"},{"key":"1943_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1182\/blood-2003-05-1449","volume":"103","author":"O Tournilhac","year":"2004","unstructured":"Tournilhac O, Cazin B, Lepr\u00e8tre S, Divin\u00e9 M, Maloum K, Delmer A, Grosbois B, Feugier P, Maloisel F, Villard F, et al. Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia. Blood. 2004;103:363\u20135.","journal-title":"Blood"},{"key":"1943_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/sj.bmt.1703775","volume":"31","author":"L Weiss","year":"2003","unstructured":"Weiss L, Abdul-Hai A, Or R, Amir G, Polliack A. Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia. Bone Marrow Transplant. 2003;31:11\u20135.","journal-title":"Bone Marrow Transplant"},{"key":"1943_CR51","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1038\/s41467-024-49978-4","volume":"15","author":"S Chouhan","year":"2024","unstructured":"Chouhan S, Sridaran D, Weimholt C, Luo J, Li T, Hodgson MC, Santos LN, Le Sommer S, Fang B, Koomen JM, et al. SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis. Nat Commun. 2024;15:5629.","journal-title":"Nat Commun"},{"key":"1943_CR52","doi-asserted-by":"publisher","first-page":"113920","DOI":"10.1016\/j.bcp.2020.113920","volume":"175","author":"YJ Lee","year":"2020","unstructured":"Lee YJ, Song H, Yoon YJ, Park SJ, Kim SY, Cho Han D, Kwon BM. Ethacrynic acid inhibits STAT3 activity through the modulation of SHP2 and PTP1B tyrosine phosphatases in DU145 prostate carcinoma cells. Biochem Pharmacol. 2020;175:113920.","journal-title":"Biochem Pharmacol"},{"key":"1943_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.celrep.2014.08.044","volume":"9","author":"A Toso","year":"2014","unstructured":"Toso A, Revandkar A, Di Mitri D, Guccini I, Proietti M, Sarti M, Pinton S, Zhang J, Kalathur M, Civenni G, et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 2014;9:75\u201389.","journal-title":"Cell Rep"},{"key":"1943_CR54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/onc.2015.184","volume":"35","author":"K Zhang","year":"2016","unstructured":"Zhang K, Zhao H, Ji Z, Zhang C, Zhou P, Wang L, Chen Q, Wang J, Zhang P, Chen Z, et al. Shp2 promotes metastasis of prostate cancer by attenuating the PAR3\/PAR6\/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition. Oncogene. 2016;35:1271\u201382.","journal-title":"Oncogene"},{"key":"1943_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2165\/00003495-200969010-00005","volume":"69","author":"AB Murphy","year":"2009","unstructured":"Murphy AB, Macejko A, Taylor A, Nadler RB. Chronic prostatitis: management strategies. Drugs. 2009;69:71\u201384.","journal-title":"Drugs"},{"key":"1943_CR56","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2016.8","volume":"19","author":"AS Polackwich","year":"2016","unstructured":"Polackwich AS, Shoskes DA. Chronic prostatitis\/chronic pelvic pain syndrome: a review of evaluation and therapy. Prostate Cancer Prostatic Dis. 2016;19:132\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1943_CR57","doi-asserted-by":"publisher","first-page":"155249","DOI":"10.1016\/j.phymed.2023.155249","volume":"123","author":"YF Liu","year":"2024","unstructured":"Liu YF, Xie WJ, Xi P, Zhang ZC, Chen R, Fu SQ, Lei KY, Liu J, Cheng XF, Nie YC, et al. Astaxanthin alleviates chronic prostatitis\/chronic pelvic pain syndrome by increasing colonization of Akkermansia muciniphila in the intestine. Phytomedicine. 2024;123:155249.","journal-title":"Phytomedicine."},{"key":"1943_CR58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrurol.2014.63","volume":"11","author":"SF Murphy","year":"2014","unstructured":"Murphy SF, Schaeffer AJ, Thumbikat P. Immune mediators of chronic pelvic pain syndrome. Nat Rev Urol. 2014;11:259\u201369.","journal-title":"Nat Rev Urol"},{"key":"1943_CR59","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.4049\/jimmunol.141.3.1018","volume":"141","author":"TJ Schall","year":"1988","unstructured":"Schall TJ, Jongstra J, Dyer BJ, Jorgensen J, Clayberger C, Davis MM, Krensky AM. A human T cell-specific molecule is a member of a new gene family. J Immunol. 1988;141:1018\u201325.","journal-title":"J Immunol"},{"key":"1943_CR60","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1172\/JCI41732","volume":"120","author":"ML Berres","year":"2010","unstructured":"Berres ML, Koenen RR, Rueland A, Zaldivar MM, Heinrichs D, Sahin H, Schmitz P, Streetz KL, Berg T, Gassler N, et al. Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest. 2010;120:4129\u201340.","journal-title":"J Clin Invest"},{"key":"1943_CR61","first-page":"605","volume":"17","author":"BJ Swanson","year":"2002","unstructured":"Swanson BJ, Murakami M, Mitchell TC, Kappler J, Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional. TCR-dependent process Immunity. 2002;17:605\u201315.","journal-title":"TCR-dependent process Immunity"},{"key":"1943_CR62","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/sj.bjp.0703870","volume":"132","author":"Y Asai","year":"2001","unstructured":"Asai Y, Hashimoto S, Kujime K, Gon Y, Mizumura K, Shimizu K, Horie T. Amantadine inhibits RANTES production by influenzavirus-infected human bronchial epithelial cells. Br J Pharmacol. 2001;132:918\u201324.","journal-title":"Br J Pharmacol"},{"key":"1943_CR63","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41419-022-04935-1","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu H, Zhao J, Li J, Zhu Z, Cui Z, Liu R, Lu R, Yao Z, Xu Q. Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1\u03b1\/ZEB1 axis. Cell Death Dis. 2022;13:478.","journal-title":"Cell Death Dis"},{"key":"1943_CR64","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1182\/blood-2015-05-644583","volume":"127","author":"KR Machlus","year":"2016","unstructured":"Machlus KR, Johnson KE, Kulenthirarajan R, Forward JA, Tippy MD, Soussou TS, El-Husayni SH, Wu SK, Wang S, Watnick RS, et al. CCL5 derived from platelets increases megakaryocyte proplatelet formation. Blood. 2016;127:921\u20136.","journal-title":"Blood"},{"key":"1943_CR65","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.phrs.2007.11.002","volume":"57","author":"A Anogianaki","year":"2008","unstructured":"Anogianaki A, Castellani ML, Madhappan B, Salini V, Vecchiet J, Tet\u00e8 S, Frydas S, Perrella A, De Lutiis MA, Neri G, et al. RANTES (CCL5) potentiates calcium ionophore in the production of LTB4 in rat adherent macrophages from granuloma induced by KMnO4: inhibiton by NDGA. Pharmacol Res. 2008;57:49\u201355.","journal-title":"Pharmacol Res"},{"key":"1943_CR66","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1164\/rccm.201012-2033OC","volume":"184","author":"C Arnaud","year":"2011","unstructured":"Arnaud C, Beguin PC, Lantuejoul S, Pepin JL, Guillermet C, Pelli G, Burger F, Buatois V, Ribuot C, Baguet JP, et al. The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES\/CCL5 inhibition. Am J Respir Crit Care Med. 2011;184:724\u201331.","journal-title":"Am J Respir Crit Care Med"},{"key":"1943_CR67","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/jmv.20091","volume":"73","author":"MB Elliott","year":"2004","unstructured":"Elliott MB, Tebbey PW, Pryharski KS, Scheuer CA, Laughlin TS, Hancock GE. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5). J Med Virol. 2004;73:300\u20138.","journal-title":"J Med Virol"},{"key":"1943_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13167-015-0032-4","volume":"6","author":"J Lechner","year":"2015","unstructured":"Lechner J, von Baehr V. Chemokine RANTES\/CCL5 as an unknown link between wound healing in the jawbone and systemic disease: is prediction and tailored treatments in the horizon? Epma j. 2015;6:10.","journal-title":"Epma j"},{"key":"1943_CR69","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jaci.2008.09.033","volume":"122","author":"M Yamin","year":"2008","unstructured":"Yamin M, Holbrook EH, Gray ST, Harold R, Busaba N, Sridhar A, Powell KJ, Hamilos DL. Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted\/CCL5 expression in chronic rhinosinusitis. J Allergy Clin Immunol. 2008;122:1145\u20131153.e1143.","journal-title":"J Allergy Clin Immunol"},{"key":"1943_CR70","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.tcb.2017.01.006","volume":"27","author":"L Catrysse","year":"2017","unstructured":"Catrysse L, van Loo G. Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-\u03baB. Trends Cell Biol. 2017;27:417\u201329.","journal-title":"Trends Cell Biol"},{"key":"1943_CR71","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-\u03baB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"key":"1943_CR72","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri1703","volume":"5","author":"M Karin","year":"2005","unstructured":"Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749\u201359.","journal-title":"Nat Rev Immunol"},{"key":"1943_CR73","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009;1:a001651.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1943_CR74","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","volume":"17","author":"SC Sun","year":"2017","unstructured":"Sun SC. The non-canonical NF-\u03baB pathway in immunity and inflammation. Nat Rev Immunol. 2017;17:545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1943_CR75","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/cr.2010.175","volume":"21","author":"A Wullaert","year":"2011","unstructured":"Wullaert A, Bonnet MC, Pasparakis M. NF-\u03baB in the regulation of epithelial homeostasis and inflammation. Cell Res. 2011;21:146\u201358.","journal-title":"Cell Res"},{"key":"1943_CR76","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1038\/s41423-023-01089-8","volume":"20","author":"J Cao","year":"2023","unstructured":"Cao J, Ji L, Zhan Y, Shao X, Xu P, Wu B, Chen P, Cheng L, Zhuang X, Ou Y, et al. MST4 kinase regulates immune thrombocytopenia by phosphorylating STAT1-mediated M1 polarization of macrophages. Cell Mol Immunol. 2023;20:1413\u201327.","journal-title":"Cell Mol Immunol"},{"key":"1943_CR77","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","volume":"18","author":"LB Ivashkiv","year":"2018","unstructured":"Ivashkiv LB. IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol. 2018;18:545\u201358.","journal-title":"Nat Rev Immunol"},{"key":"1943_CR78","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41423-022-00904-y","volume":"19","author":"T Shao","year":"2022","unstructured":"Shao T, Leung PSC, Zhang W, Tsuneyama K, Ridgway WM, Young HA, Shuai Z, Ansari AA, Gershwin ME. Treatment with a JAK1\/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression. Cell Mol Immunol. 2022;19:1130\u201340.","journal-title":"Cell Mol Immunol"},{"key":"1943_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.canlet.2019.12.013","volume":"472","author":"L Shen","year":"2020","unstructured":"Shen L, Kang L, Wang D, Xun J, Chen C, Du L, Zhang M, Gong J, Mi X, Yue S, et al. Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1\/STAT1 activation. Cancer Lett. 2020;472:40\u20139.","journal-title":"Cancer Lett"},{"key":"1943_CR80","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1158\/0008-5472.CAN-15-2663","volume":"76","author":"X Su","year":"2016","unstructured":"Su X, Esser AK, Amend SR, Xiang J, Xu Y, Ross MH, Fox GC, Kobayashi T, Steri V, Roomp K, et al. Antagonizing Integrin \u03b23 Increases Immunosuppression in Cancer. Cancer Res. 2016;76:3484\u201395.","journal-title":"Cancer Res"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01943-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01943-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01943-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T10:45:46Z","timestamp":1733395546000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01943-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01943-w","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,5]]},"assertion":[{"value":"19 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants, including obtaining written informed consent, were conducted in accordance with the principles outlined in the Helsinki Declaration and were approved by the Ethics Committee of the First Affiliated Hospital of Anhui Medical University on June 10, 2020 (PJ-2020\u201307-11). Written informed consent was obtained from all participants involved in this study. All animal experiments were conducted in compliance with the guidelines of the Animal Care and Utilization Committee of the Animal Center of Anhui Medical University, with approval (approval no. LLSC20241750).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained from all participants involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"584"}}